Matches in Wikidata for { <http://www.wikidata.org/entity/Q94982451> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q94982451 description "clinical trial" @default.
- Q94982451 description "ensayo clínico" @default.
- Q94982451 description "ensayu clínicu" @default.
- Q94982451 description "klinisch onderzoek" @default.
- Q94982451 description "клінічне випробування" @default.
- Q94982451 description "临床试验" @default.
- Q94982451 name "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 name "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 type Item @default.
- Q94982451 label "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 label "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 prefLabel "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 prefLabel "Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer" @default.
- Q94982451 P1050 Q94982451-E03AC6DF-653C-4730-B304-DFB6960D9869 @default.
- Q94982451 P1132 Q94982451-33D979D7-9450-4BF1-BD58-645ACFBE8076 @default.
- Q94982451 P1476 Q94982451-E4231CE3-F863-456A-8BCD-13B2204D7971 @default.
- Q94982451 P2899 Q94982451-4CC0CB06-A891-4553-9A48-F4E09880C0E1 @default.
- Q94982451 P3098 Q94982451-8C71717E-E857-4EE7-888C-79923A20702C @default.
- Q94982451 P31 Q94982451-8CC65217-58B0-4CD7-B85E-9858D97F5ADB @default.
- Q94982451 P4135 Q94982451-E4AAAE75-D691-468A-85E7-066F570D03DB @default.
- Q94982451 P4844 Q94982451-DE440531-ED3E-4BC4-AE52-C756A45D6DD9 @default.
- Q94982451 P4844 Q94982451-F80211A7-27E8-49A3-B574-2A6F2C8165BA @default.
- Q94982451 P580 Q94982451-9C19FD00-FD69-4E52-935B-95E9072A9482 @default.
- Q94982451 P582 Q94982451-738182E9-B75F-4F55-A062-93EAD7EB5366 @default.
- Q94982451 P6099 Q94982451-01DC993D-8A0F-4FFF-BD39-FBDA111EA6D0 @default.
- Q94982451 P8005 Q94982451-5F613897-FDBE-43BA-9FB0-AF6A3C04D09B @default.
- Q94982451 P8363 Q94982451-1D6A48F0-5623-44FC-9C25-66CB0F39C3D8 @default.
- Q94982451 P1050 Q33525 @default.
- Q94982451 P1132 "+560" @default.
- Q94982451 P1476 "A Phase III, Randomized, Open-label, Active Controlled, Multicenter Study on Toripalimab Combined With Axitinib Versus Sunitinib Monotheraphy as a First-Line Treatment for Unresectable or Metastatic Renal Cell Carcinoma (RCC)" @default.
- Q94982451 P2899 "+18" @default.
- Q94982451 P3098 "NCT04394975" @default.
- Q94982451 P31 Q30612 @default.
- Q94982451 P4135 "+80" @default.
- Q94982451 P4844 Q417542 @default.
- Q94982451 P4844 Q4830631 @default.
- Q94982451 P580 "2020-06-19T00:00:00Z" @default.
- Q94982451 P582 "2023-06-30T00:00:00Z" @default.
- Q94982451 P6099 Q42824827 @default.
- Q94982451 P8005 Q76649614 @default.
- Q94982451 P8363 Q78089383 @default.